Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 97 to 108 of 108 entries
Sorted by: Best Match Show Resources per page
Algal cultivation in urban wastewater: an efficient way to reduce pharmaceutical pollutants.

Journal of applied phycology

Gentili FG, Fick J.
PMID: 28344390
J Appl Phycol. 2017;29(1):255-262. doi: 10.1007/s10811-016-0950-0. Epub 2016 Sep 03.

The purpose of this study was to investigate whether pharmaceutical pollutants in urban wastewater can be reduced during algal cultivation. A mixed population of wild freshwater green algal species was grown on urban wastewater influent in a 650 L...

Cite
Gentili FG, Fick J. Algal cultivation in urban wastewater: an efficient way to reduce pharmaceutical pollutants. J Appl Phycol. 2016;29(1):255-262doi: 10.1007/s10811-016-0950-0.
Gentili, F. G., & Fick, J. (2017). Algal cultivation in urban wastewater: an efficient way to reduce pharmaceutical pollutants. Journal of applied phycology, 29(1), 255-262. https://doi.org/10.1007/s10811-016-0950-0
Gentili, Francesco G, and Fick, Jerker. "Algal cultivation in urban wastewater: an efficient way to reduce pharmaceutical pollutants." Journal of applied phycology vol. 29,1 (2017): 255-262. doi: https://doi.org/10.1007/s10811-016-0950-0
Gentili FG, Fick J. Algal cultivation in urban wastewater: an efficient way to reduce pharmaceutical pollutants. J Appl Phycol. 2017;29(1):255-262. doi: 10.1007/s10811-016-0950-0. Epub 2016 Sep 03. PMID: 28344390; PMCID: PMC5346144.
Copy Download .nbib Format: NLM
Concurrent oral and inhalation drug delivery using a dual formulation system: the use of oral theophylline carrier with combined inhalable budesonide and terbutaline.

Drug delivery and translational research

Salama RO, Young PM, Traini D.
PMID: 25786880
Drug Deliv Transl Res. 2014 Jun;4(3):256-67. doi: 10.1007/s13346-013-0137-z.

A novel approach to concurrently deliver oral and inhaled drugs as a single formulation is presented. A triple therapy containing theophylline (THEO; orally delivered) with budesonide (BUD) and terbutaline (TERB; as single and co-spray-dried inhaled powders) was prepared as...

Cite
Salama RO, Young PM, Traini D. Concurrent oral and inhalation drug delivery using a dual formulation system: the use of oral theophylline carrier with combined inhalable budesonide and terbutaline. Drug Deliv Transl Res. 2014;4(3):256-67doi: 10.1007/s13346-013-0137-z.
Salama, R. O., Young, P. M., & Traini, D. (2014). Concurrent oral and inhalation drug delivery using a dual formulation system: the use of oral theophylline carrier with combined inhalable budesonide and terbutaline. Drug delivery and translational research, 4(3), 256-67. https://doi.org/10.1007/s13346-013-0137-z
Salama, Rania O, et al. "Concurrent oral and inhalation drug delivery using a dual formulation system: the use of oral theophylline carrier with combined inhalable budesonide and terbutaline." Drug delivery and translational research vol. 4,3 (2014): 256-67. doi: https://doi.org/10.1007/s13346-013-0137-z
Salama RO, Young PM, Traini D. Concurrent oral and inhalation drug delivery using a dual formulation system: the use of oral theophylline carrier with combined inhalable budesonide and terbutaline. Drug Deliv Transl Res. 2014 Jun;4(3):256-67. doi: 10.1007/s13346-013-0137-z. PMID: 25786880.
Copy Download .nbib Format: NLM
Effects of Beta-Blocker Titration on Glucose Homeostasis in Heart Failure.

The Journal of pharmacy technology : jPT : official publication of the Association of Pharmacy Technicians

Vardeny O, Zebrack J, Gilbert EM, Cheang KI.
PMID: 19675680
J Pharm Technol. 2009;25(2):71-78. doi: 10.1177/875512250902500202.

BACKGROUND: Abnormal glucose metabolism and insulin resistance have been associated with heart failure incidence, severity, and mortality. Metabolic parameters such as hepatic glucose production may be altered by beta-adrenoceptor antagonists in patients with heart failure. OBJECTIVE: This study evaluated...

Cite
Vardeny O, Zebrack J, Gilbert EM, et al. Effects of Beta-Blocker Titration on Glucose Homeostasis in Heart Failure. J Pharm Technol. 2009;25(2):71-78doi: 10.1177/875512250902500202.
Vardeny, O., Zebrack, J., Gilbert, E. M., & Cheang, K. I. (2009). Effects of Beta-Blocker Titration on Glucose Homeostasis in Heart Failure. The Journal of pharmacy technology : jPT : official publication of the Association of Pharmacy Technicians, 25(2), 71-78. https://doi.org/10.1177/875512250902500202
Vardeny, Orly, et al. "Effects of Beta-Blocker Titration on Glucose Homeostasis in Heart Failure." The Journal of pharmacy technology : jPT : official publication of the Association of Pharmacy Technicians vol. 25,2 (2009): 71-78. doi: https://doi.org/10.1177/875512250902500202
Vardeny O, Zebrack J, Gilbert EM, Cheang KI. Effects of Beta-Blocker Titration on Glucose Homeostasis in Heart Failure. J Pharm Technol. 2009;25(2):71-78. doi: 10.1177/875512250902500202. PMID: 19675680; PMCID: PMC2724721.
Copy Download .nbib Format: NLM
Formulation and optimization of sustained release terbutaline sulfate microspheres using response surface methodology.

Drug discoveries & therapeutics

Khattab I, Bandarkar F, Lila A.
PMID: 22495540
Drug Discov Ther. 2009 Jun;3(3):123-35.

The present study reports the optimization of sustained release microspheres of terbutaline sulfate (TS) and Eudragit RSPM using response surface methodology. The microspheres were prepared by the emulsion solvent evaporation process utilizing Eudragit RSPM as release retarding agent. A...

Cite
Khattab I, Bandarkar F, Lila A. Formulation and optimization of sustained release terbutaline sulfate microspheres using response surface methodology. Drug Discov Ther. 2009;3(3):123-35
Khattab, I., Bandarkar, F., & Lila, A. (2009). Formulation and optimization of sustained release terbutaline sulfate microspheres using response surface methodology. Drug discoveries & therapeutics, 3(3), 123-35.
Khattab, I, et al. "Formulation and optimization of sustained release terbutaline sulfate microspheres using response surface methodology." Drug discoveries & therapeutics vol. 3,3 (2009): 123-35.
Khattab I, Bandarkar F, Lila A. Formulation and optimization of sustained release terbutaline sulfate microspheres using response surface methodology. Drug Discov Ther. 2009 Jun;3(3):123-35. PMID: 22495540.
Copy Download .nbib Format: NLM
Targeting α- and β-Adrenergic Receptors Differentially Shifts Th1, Th2, and Inflammatory Cytokine Profiles in Immune Organs to Attenuate Adjuvant Arthritis.

Frontiers in immunology

Lubahn CL, Lorton D, Schaller JA, Sweeney SJ, Bellinger DL.
PMID: 25157248
Front Immunol. 2014 Aug 11;5:346. doi: 10.3389/fimmu.2014.00346. eCollection 2014.

The sympathetic nervous system (SNS) regulates host defense responses and restores homeostasis. SNS-immune regulation is altered in rheumatoid arthritis (RA) and rodent models of RA, characterized by nerve remodeling in immune organs and defective adrenergic receptor (AR) signaling to...

Cite
Lubahn CL, Lorton D, Schaller JA, et al. Targeting α- and β-Adrenergic Receptors Differentially Shifts Th1, Th2, and Inflammatory Cytokine Profiles in Immune Organs to Attenuate Adjuvant Arthritis. Front Immunol. 2014;5:346doi: 10.3389/fimmu.2014.00346.
Lubahn, C. L., Lorton, D., Schaller, J. A., Sweeney, S. J., & Bellinger, D. L. (2014). Targeting α- and β-Adrenergic Receptors Differentially Shifts Th1, Th2, and Inflammatory Cytokine Profiles in Immune Organs to Attenuate Adjuvant Arthritis. Frontiers in immunology, 5346. https://doi.org/10.3389/fimmu.2014.00346
Lubahn, Cheri L, et al. "Targeting α- and β-Adrenergic Receptors Differentially Shifts Th1, Th2, and Inflammatory Cytokine Profiles in Immune Organs to Attenuate Adjuvant Arthritis." Frontiers in immunology vol. 5 (2014): 346. doi: https://doi.org/10.3389/fimmu.2014.00346
Lubahn CL, Lorton D, Schaller JA, Sweeney SJ, Bellinger DL. Targeting α- and β-Adrenergic Receptors Differentially Shifts Th1, Th2, and Inflammatory Cytokine Profiles in Immune Organs to Attenuate Adjuvant Arthritis. Front Immunol. 2014 Aug 11;5:346. doi: 10.3389/fimmu.2014.00346. eCollection 2014. PMID: 25157248; PMCID: PMC4127464.
Copy Download .nbib Format: NLM
Extravasation of Noncytotoxic Drugs: A Review of the Literature.

The Annals of pharmacotherapy

Le A, Patel S.
PMID: 24714850
Ann Pharmacother. 2014 Jul;48(7):870-886. doi: 10.1177/1060028014527820. Epub 2014 Apr 08.

OBJECTIVE: Extravasation is a potential complication associated with intravenous therapy administration. Inadvertent leakage of medications with vesicant properties can cause severe tissue necrosis, which can lead to devastating long-term consequences. Recognizing potential agents is an essential step in mitigating...

Cite
Le A, Patel S. Extravasation of Noncytotoxic Drugs: A Review of the Literature. Ann Pharmacother. 2014;48(7):870-886doi: 10.1177/1060028014527820.
Le, A., & Patel, S. (2014). Extravasation of Noncytotoxic Drugs: A Review of the Literature. The Annals of pharmacotherapy, 48(7), 870-886. https://doi.org/10.1177/1060028014527820
Le, Ann, and Patel, Samit. "Extravasation of Noncytotoxic Drugs: A Review of the Literature." The Annals of pharmacotherapy vol. 48,7 (2014): 870-886. doi: https://doi.org/10.1177/1060028014527820
Le A, Patel S. Extravasation of Noncytotoxic Drugs: A Review of the Literature. Ann Pharmacother. 2014 Jul;48(7):870-886. doi: 10.1177/1060028014527820. Epub 2014 Apr 08. PMID: 24714850.
Copy Download .nbib Format: NLM
Treatment of Priapism Secondary to Drugs for Erectile Dysfunction.

Advances in urology

Saffon Cuartas JP, Sandoval-Salinas C, Martínez JM, Corredor HA.
PMID: 31534452
Adv Urol. 2019 Aug 22;2019:6214921. doi: 10.1155/2019/6214921. eCollection 2019.

Priapism may present as a side effect in patients treated with medications for erectile dysfunction, in which it should be controlled in a timely manner to avoid complications. There is little information regarding the use of local measures for...

Cite
Saffon Cuartas JP, Sandoval-Salinas C, Martínez JM, et al. Treatment of Priapism Secondary to Drugs for Erectile Dysfunction. Adv Urol. 2019;2019:6214921doi: 10.1155/2019/6214921.
Saffon Cuartas, J. P., Sandoval-Salinas, C., Martínez, J. M., & Corredor, H. A. (2019). Treatment of Priapism Secondary to Drugs for Erectile Dysfunction. Advances in urology, 20196214921. https://doi.org/10.1155/2019/6214921
Saffon Cuartas, José Pablo, et al. "Treatment of Priapism Secondary to Drugs for Erectile Dysfunction." Advances in urology vol. 2019 (2019): 6214921. doi: https://doi.org/10.1155/2019/6214921
Saffon Cuartas JP, Sandoval-Salinas C, Martínez JM, Corredor HA. Treatment of Priapism Secondary to Drugs for Erectile Dysfunction. Adv Urol. 2019 Aug 22;2019:6214921. doi: 10.1155/2019/6214921. eCollection 2019. PMID: 31534452; PMCID: PMC6724441.
Copy Download .nbib Format: NLM
Paradoxical bronchoconstriction caused by β.

Drug target insights

Ayed K, Khalifa ILH, Mokaddem S, Jameleddine SBK.
PMID: 33132694
Drug Target Insights. 2020 Oct 05;14:12-15. doi: 10.33393/dti.2020.2188. eCollection 2020.

INTRODUCTION: Salbutamol and terbutaline are short-acting βMETHODS: This case is about a 50-year-old asthmatic patient who describes a history of repeated acute asthma attacks after salbutamol inhalation or terbutaline nebulization. A double-blind crossover study was performed over 3 days,...

Cite
Ayed K, Khalifa ILH, Mokaddem S, et al. Paradoxical bronchoconstriction caused by β. Drug Target Insights. 2020;14:12-15doi: 10.33393/dti.2020.2188.
Ayed, K., Khalifa, I. L. H., Mokaddem, S., & Jameleddine, S. B. K. (2020). Paradoxical bronchoconstriction caused by β. Drug target insights, 1412-15. https://doi.org/10.33393/dti.2020.2188
Ayed, Khadija, et al. "Paradoxical bronchoconstriction caused by β." Drug target insights vol. 14 (2020): 12-15. doi: https://doi.org/10.33393/dti.2020.2188
Ayed K, Khalifa ILH, Mokaddem S, Jameleddine SBK. Paradoxical bronchoconstriction caused by β. Drug Target Insights. 2020 Oct 05;14:12-15. doi: 10.33393/dti.2020.2188. eCollection 2020. PMID: 33132694; PMCID: PMC7597223.
Copy Download .nbib Format: NLM
Synchronous fluorescence as a green and selective tool for simultaneous determination of bambuterol and its main degradation product, terbutaline.

Royal Society open science

Abo El Abass S, Elmansi H.
PMID: 30473864
R Soc Open Sci. 2018 Oct 31;5(10):181359. doi: 10.1098/rsos.181359. eCollection 2018 Oct.

A green, sensitive and cost-effective method is introduced in this research for the determination of bambuterol and its main degradation product, terbutaline, simultaneously, relying on the synchronous spectrofluorimetric technique. First derivative synchronous spectrofluorimetric amplitude is measured at Δ

Cite
Abo El Abass S, Elmansi H. Synchronous fluorescence as a green and selective tool for simultaneous determination of bambuterol and its main degradation product, terbutaline. R Soc Open Sci. 2018;5(10):181359doi: 10.1098/rsos.181359.
Abo El Abass, S., & Elmansi, H. (2018). Synchronous fluorescence as a green and selective tool for simultaneous determination of bambuterol and its main degradation product, terbutaline. Royal Society open science, 5(10), 181359. https://doi.org/10.1098/rsos.181359
Abo El Abass, Samah, and Elmansi, Heba. "Synchronous fluorescence as a green and selective tool for simultaneous determination of bambuterol and its main degradation product, terbutaline." Royal Society open science vol. 5,10 (2018): 181359. doi: https://doi.org/10.1098/rsos.181359
Abo El Abass S, Elmansi H. Synchronous fluorescence as a green and selective tool for simultaneous determination of bambuterol and its main degradation product, terbutaline. R Soc Open Sci. 2018 Oct 31;5(10):181359. doi: 10.1098/rsos.181359. eCollection 2018 Oct. PMID: 30473864; PMCID: PMC6227927.
Copy Download .nbib Format: NLM
Beat-to-Beat Measurement of Cardiovascular Effects of a Single Subcutaneous Dose of Terbutaline in Healthy Subjects.

Clinical drug investigation

Mulder WMC, de Klerk S, Settels JJ, van Boxtel CJ.
PMID: 29492853
Clin Drug Investig. 2002 Sep;22(9):593-600. doi: 10.2165/00044011-200222090-00004.

OBJECTIVE: To evaluate the cardiovascular effects over time of a single subcutaneous (SC) dose of terbutaline 0.75mg in young healthy volunteers using continuous, beat-to-beat monitoring of cardiovascular effects.DESIGN AND METHODS: Nine healthy young volunteers were administered a SC dose...

Cite
Mulder WMC, de Klerk S, Settels JJ, et al. Beat-to-Beat Measurement of Cardiovascular Effects of a Single Subcutaneous Dose of Terbutaline in Healthy Subjects. Clin Drug Investig. 2002;22(9):593-600doi: 10.2165/00044011-200222090-00004.
Mulder, W. M. C., de Klerk, S., Settels, J. J., & van Boxtel, C. J. (2002). Beat-to-Beat Measurement of Cardiovascular Effects of a Single Subcutaneous Dose of Terbutaline in Healthy Subjects. Clinical drug investigation, 22(9), 593-600. https://doi.org/10.2165/00044011-200222090-00004
Mulder, W M C, et al. "Beat-to-Beat Measurement of Cardiovascular Effects of a Single Subcutaneous Dose of Terbutaline in Healthy Subjects." Clinical drug investigation vol. 22,9 (2002): 593-600. doi: https://doi.org/10.2165/00044011-200222090-00004
Mulder WMC, de Klerk S, Settels JJ, van Boxtel CJ. Beat-to-Beat Measurement of Cardiovascular Effects of a Single Subcutaneous Dose of Terbutaline in Healthy Subjects. Clin Drug Investig. 2002 Sep;22(9):593-600. doi: 10.2165/00044011-200222090-00004. PMID: 29492853.
Copy Download .nbib Format: NLM
Use of aerosol inhalation treatment with budesonide and terbutaline sulfate on acute pediatric asthmatic bronchitis.

Experimental and therapeutic medicine

Bian F, Wu YE, Zhang CL.
PMID: 28810628
Exp Ther Med. 2017 Aug;14(2):1621-1625. doi: 10.3892/etm.2017.4676. Epub 2017 Jun 26.

The use of oxygen-driven aerosol inhalation therapy with budesonide (suspension) and terbutaline sulfate for the treatment of pediatric asthmatic bronchitis was studied. Sixty pediatric patients diagnosed with asthmatic bronchitis in Xuzhou Children's Hospital during the period comprising April 2013...

Cite
Bian F, Wu YE, Zhang CL. Use of aerosol inhalation treatment with budesonide and terbutaline sulfate on acute pediatric asthmatic bronchitis. Exp Ther Med. 2017;14(2):1621-1625doi: 10.3892/etm.2017.4676.
Bian, F., Wu, Y. E., & Zhang, C. L. (2017). Use of aerosol inhalation treatment with budesonide and terbutaline sulfate on acute pediatric asthmatic bronchitis. Experimental and therapeutic medicine, 14(2), 1621-1625. https://doi.org/10.3892/etm.2017.4676
Bian, Fangfang, et al. "Use of aerosol inhalation treatment with budesonide and terbutaline sulfate on acute pediatric asthmatic bronchitis." Experimental and therapeutic medicine vol. 14,2 (2017): 1621-1625. doi: https://doi.org/10.3892/etm.2017.4676
Bian F, Wu YE, Zhang CL. Use of aerosol inhalation treatment with budesonide and terbutaline sulfate on acute pediatric asthmatic bronchitis. Exp Ther Med. 2017 Aug;14(2):1621-1625. doi: 10.3892/etm.2017.4676. Epub 2017 Jun 26. PMID: 28810628; PMCID: PMC5526142.
Copy Download .nbib Format: NLM
Association of Antenatal Terbutaline and Respiratory Support Requirements in Preterm Neonates.

American journal of perinatology

Kittiarpornpon V, Siripattanapipong P, Bowornkitiwong W, Kitsommart R, Ngerncham S, Wongsiridach P, Yangthara B.
PMID: 34768291
Am J Perinatol. 2021 Nov 12; doi: 10.1055/a-1695-8220. Epub 2021 Nov 12.

BACKGROUND:  Before the advent of antenatal steroids, early non-invasive respiratory support (NIV), and intratracheal surfactant, antenatal terbutaline was also used to improve lung compliance and reduce the incidence of respiratory distress syndrome (RDS).OBJECTIVES:  The objective of this paper was...

Cite
Kittiarpornpon V, Siripattanapipong P, Bowornkitiwong W, et al. Association of Antenatal Terbutaline and Respiratory Support Requirements in Preterm Neonates. Am J Perinatol. 2021;doi: 10.1055/a-1695-8220.
Kittiarpornpon, V., Siripattanapipong, P., Bowornkitiwong, W., Kitsommart, R., Ngerncham, S., Wongsiridach, P., & Yangthara, B. (2021). Association of Antenatal Terbutaline and Respiratory Support Requirements in Preterm Neonates. American journal of perinatology, . https://doi.org/10.1055/a-1695-8220
Kittiarpornpon, Visanu, et al. "Association of Antenatal Terbutaline and Respiratory Support Requirements in Preterm Neonates." American journal of perinatology vol. (2021). doi: https://doi.org/10.1055/a-1695-8220
Kittiarpornpon V, Siripattanapipong P, Bowornkitiwong W, Kitsommart R, Ngerncham S, Wongsiridach P, Yangthara B. Association of Antenatal Terbutaline and Respiratory Support Requirements in Preterm Neonates. Am J Perinatol. 2021 Nov 12; doi: 10.1055/a-1695-8220. Epub 2021 Nov 12. PMID: 34768291.
Copy Download .nbib Format: NLM
Showing 97 to 108 of 108 entries